Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Upstage Lung Cancer is a 501(c)(3) non-profit organization dedicated to increasing awareness and funding research for the early detection of lung cancer. Founded in 2008 by lung cancer survivor Hildy Grossman, the organization uniquely utilizes music and the performing arts to raise funds and reduce the social stigma associated with the disease. Upstage Lung Cancer has invested over $4 million in research partnerships with leading institutions such as the MIT Koch Institute and the Dana-Farber Cancer Institute. Their primary focus is on supporting the development of non-invasive diagnostic tools, including blood, breath, and urine tests, to identify lung cancer at its most treatable stages. The organization also produces the "Backstage @ Upstage" podcast and hosts educational concerts to engage the patient and medical communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Upstage Lung Cancer.